The oncology community is well aware that cancer therapy is fraught with increased risk of cardiovascular disease (CVD). Of the almost 12 million cancer survivors in the United States, many are more likely to die of CVD...
Some patients with early breast cancer had a benefit in clinical response rate when everolimus was added to trastuzumab treatment, though the benefit was statistically nonsignificant. These puzzling results suggested that this benefit was independent of the molecular pathways that could be expected to be involved.
A new class of drugs targeting the genetic material of skin cancer has been successfully tested in humans for the first time. This opens the way to new treatments for a range of conditions from skin cancers to eye diseases.
The FDA is proposing that indoor tanning beds and booths carry labels that warn minors not to use these products.
For older men with nonmetastatic prostate cancer, comorbidities increase risk of other-cause death mortality.
Increased polyp and adenoma detection rates are associated with use of full-spectrum endoscopy colonoscope.
High fitness has been linked to reductions in risk of developing and dying from lung, colorectal cancer.
Ann J. Brady, MSN, RN-BC
Jia Conway, DNP, FNP-BC, AOCNP, NP-C
Michele M. Farrington, BSN, RN, CPHON
Donald R. Fleming, MD
Arati Jairam-Thodla, MSN, CNP
Karen MacDonald, RN, BSN, CPON
Marlene McGuire, RN, MA, ANP-C
Kerstin L. McSteen, BSN, MSN, ACHPN, CNS-BC
Helen H. Miller, LCSW, ACSW
Maribel Pereiras, PharmD, BCPS, BCOP
Leah A. Scaramuzzo, MSN, RN-BC, AOCN
Lisa A. Thompson, PharmD, BCOP
Rosemarie A. Tucci, RN, MSN, AOCN
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|